A Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic Melanoma
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety and efficacy of a combination of ipilimumab and
fotemustine in Patients with Unresectable Locally Advanced or Metastatic Malignant Melanoma.